{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:16:22Z","timestamp":1768277782437,"version":"3.49.0"},"reference-count":92,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00559","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T08:51:52Z","timestamp":1481100712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Context-Specific and Immune Cell-Dependent Antitumor Activities of \u03b11-Antitrypsin"],"prefix":"10.3389","volume":"7","author":[{"given":"Ofer","family":"Guttman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella S.","family":"Freixo-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Kaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotam","family":"Lior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peleg","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,12,7]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cei.12476","article-title":"Acute-phase protein alpha1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats","volume":"179","author":"Guttman","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"B2","doi-asserted-by":"publisher","first-page":"E1418","DOI":"10.1210\/jc.2013-3864","article-title":"Alpha1-antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes","volume":"99","author":"Gottlieb","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-2005-869536","article-title":"A review of alpha-1 antitrypsin deficiency","volume":"26","author":"Ranes","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"issue":"42","key":"B4","doi-asserted-by":"publisher","first-page":"16236","DOI":"10.1073\/pnas.0807627105","article-title":"Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice","volume":"105","author":"Lewis","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"B5","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.1073\/pnas.0505579102","article-title":"Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice","volume":"102","author":"Lewis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/1932296814547096","article-title":"Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes","volume":"8","author":"Fleixo-Lima","year":"2014","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"B7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1073\/pnas.1117665109","article-title":"Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"109","author":"Tawara","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"B8","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/MIB.0b013e31829292aa","article-title":"Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis","volume":"19","author":"Collins","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11011-011-9239-9","article-title":"Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice","volume":"26","author":"Subramanian","year":"2011","journal-title":"Metab Brain Dis"},{"issue":"12","key":"B10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/ard.50.12.915","article-title":"Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis","volume":"50","author":"Chidwick","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"B11","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1074\/jbc.275.11.7693","article-title":"Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin","volume":"275","author":"Moraga","year":"2000","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"B12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0167-4838(99)00264-2","article-title":"S-nitrosylated human alpha(1)-protease inhibitor","volume":"1477","author":"Miyamoto","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"B13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1165\/rcmb.2006-0345OC","article-title":"Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages","volume":"37","author":"Churg","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4049\/jimmunol.1101340","article-title":"Alpha-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells","volume":"189","author":"Ozeri","year":"2012","journal-title":"J Immunol"},{"issue":"4","key":"B15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cmi.2014.17","article-title":"Alpha1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation","volume":"11","author":"Abecassis","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/0470856734.ch10","article-title":"Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"256","author":"Mantovani","year":"2004","journal-title":"Novartis Found Symp"},{"key":"B17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/imm.12403","article-title":"Alpha1-antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet beta-cells in favor of protection from autoimmune diabetes","volume":"144","author":"Guttman","year":"2014","journal-title":"Immunology"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ijc.20494","article-title":"Alpha1-antitrypsin inhibits angiogenesis and tumor growth","volume":"112","author":"Huang","year":"2004","journal-title":"Int J Cancer"},{"issue":"3","key":"B19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1210\/endo.133.3.8365378","article-title":"Alpha 1-antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells","volume":"133","author":"Finlay","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"B20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1210\/endo-127-3-1319","article-title":"Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell sublines","volume":"127","author":"Tamir","year":"1990","journal-title":"Endocrinology"},{"issue":"3","key":"B21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1210\/jc.82.3.745","article-title":"Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells","volume":"82","author":"Yavelow","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"B22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front Biosci"},{"issue":"13","key":"B25","doi-asserted-by":"publisher","first-page":"E1211","DOI":"10.1073\/pnas.1321347111","article-title":"M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7","volume":"111","author":"Xiao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1 Suppl","key":"B26","first-page":"131.133","article-title":"Commensal exopolysaccharides induce M2 macrophages that prevent pathogen-induced colitis","volume":"196","author":"Paynich","year":"2016","journal-title":"J Immunol"},{"issue":"3","key":"B27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1189\/jlb.0311124","article-title":"SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis","volume":"90","author":"Weisser","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"11","key":"B28","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/eji.201343981","article-title":"Arginase activity in alternatively activated macrophages protects PI3Kp110delta deficient mice from dextran sodium sulfate induced intestinal inflammation","volume":"44","author":"Weisser","year":"2014","journal-title":"Eur J Immunol"},{"issue":"1","key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/1352458510379243","article-title":"Altered M1\/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration","volume":"17","author":"Mikita","year":"2011","journal-title":"Mult Scler"},{"issue":"1","key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages","volume":"66","author":"Allavena","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"B31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.20150295","article-title":"The interaction of anticancer therapies with tumor-associated macrophages","volume":"212","author":"Mantovani","year":"2015","journal-title":"J Exp Med"},{"issue":"2","key":"B32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett"},{"issue":"5","key":"B33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"B34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","article-title":"The origin and function of tumor-associated macrophages","volume":"13","author":"Mantovani","year":"1992","journal-title":"Immunol Today"},{"issue":"1","key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"B36","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.4049\/jimmunol.176.8.5023","article-title":"Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype","volume":"176","author":"Hagemann","year":"2006","journal-title":"J Immunol"},{"issue":"49","key":"B37","doi-asserted-by":"publisher","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4049\/jimmunol.1000413","article-title":"Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility","volume":"185","author":"Solinas","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"B39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"B40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","article-title":"FcRgamma activation regulates inflammation-associated squamous carcinogenesis","volume":"17","author":"Andreu","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"B41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"de Visser","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"B42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hep.23291","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells","volume":"51","author":"Kuang","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"B43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"issue":"24","key":"B44","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1182\/blood-2009-11-253260","article-title":"Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment","volume":"115","author":"Clear","year":"2010","journal-title":"Blood"},{"issue":"23","key":"B45","doi-asserted-by":"publisher","first-page":"11238","DOI":"10.1158\/0008-5472.CAN-06-1278","article-title":"Macrophages regulate the angiogenic switch in a mouse model of breast cancer","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"B46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"B47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"issue":"9255","key":"B48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"B49","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"B50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov"},{"issue":"5","key":"B51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2407-10-112","article-title":"The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time","volume":"10","author":"Ma","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"B53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4049\/jimmunol.174.2.636","article-title":"Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease","volume":"174","author":"Sinha","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"B54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ijc.24401","article-title":"Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages","volume":"125","author":"Duluc","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"B55","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.20080124","article-title":"An antiinflammatory role for IKKbeta through the inhibition of \u201cclassical\u201d macrophage activation","volume":"205","author":"Fong","year":"2008","journal-title":"J Exp Med"},{"issue":"4","key":"B56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s001090050364","article-title":"Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium","volume":"77","author":"Dhami","year":"1999","journal-title":"J Mol Med"},{"issue":"4","key":"B57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1074-7613(00)80638-X","article-title":"The Ets-1 transcription factor is required for the development of natural killer cells in mice","volume":"9","author":"Barton","year":"1998","journal-title":"Immunity"},{"issue":"6354","key":"B58","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/354528a0","article-title":"Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter","volume":"354","author":"Powis","year":"1991","journal-title":"Nature"},{"issue":"4","key":"B59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/7403","article-title":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo","volume":"5","author":"Fernandez","year":"1999","journal-title":"Nat Med"},{"issue":"9\u201310","key":"B60","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2119\/molmed.2011.00145","article-title":"Alpha-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection","volume":"17","author":"Shahaf","year":"2011","journal-title":"Mol Med"},{"issue":"5","key":"B61","doi-asserted-by":"publisher","first-page":"e63625","DOI":"10.1371\/journal.pone.0063625","article-title":"Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4\/CD8 therapy","volume":"8","author":"Ashkenazi","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"B62","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M112.433755","article-title":"Multilevel regulation of 2-Cys peroxiredoxin reaction cycle by S-nitrosylation","volume":"288","author":"Engelman","year":"2013","journal-title":"J Biol Chem"},{"issue":"9","key":"B63","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","article-title":"Acute phase protein alpha1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses","volume":"211","author":"Kaner","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"B64","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/imm.12149","article-title":"Human alpha1-antitrypsin modifies B-lymphocyte responses during allograft transplantation","volume":"140","author":"Mizrahi","year":"2013","journal-title":"Immunology"},{"issue":"5","key":"B65","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.4049\/jimmunol.1202797","article-title":"NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge","volume":"192","author":"Bouwer","year":"2014","journal-title":"J Immunol"},{"issue":"6055","key":"B66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"Karre","year":"1986","journal-title":"Nature"},{"issue":"2","key":"B67","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4049\/jimmunol.131.2.1024","article-title":"In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats","volume":"131","author":"Barlozzari","year":"1983","journal-title":"J Immunol"},{"issue":"5647","key":"B68","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.1090148","article-title":"Control of effector CD8+ T cell function by the transcription factor eomesodermin","volume":"302","author":"Pearce","year":"2003","journal-title":"Science"},{"issue":"35","key":"B69","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B70","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4049\/jimmunol.165.2.869","article-title":"Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin","volume":"165","author":"van Hall","year":"2000","journal-title":"J Immunol"},{"issue":"42","key":"B71","doi-asserted-by":"publisher","first-page":"16242","DOI":"10.1073\/pnas.0808031105","article-title":"Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice","volume":"105","author":"Koulmanda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B72","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J Exp Med"},{"issue":"12","key":"B73","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1084\/jem.20040317","article-title":"The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80\/86 costimulation","volume":"199","author":"Fujii","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"B74","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"B75","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1158\/0008-5472.CAN-04-0842","article-title":"Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice","volume":"64","author":"Serganova","year":"2004","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2119\/molmed.2011.00196","article-title":"Expanding the clinical indications for alpha(1)-antitrypsin therapy","volume":"18","author":"Lewis","year":"2012","journal-title":"Mol Med"},{"issue":"5","key":"B77","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1164\/ajrccm\/140.5.1494","article-title":"Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society","volume":"140","author":"Anonymous","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"B78","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archinte.168.10.1097","article-title":"Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk","volume":"168","author":"Yang","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5","key":"B79","first-page":"461","article-title":"Alpha1-antitrypsin deficiency allele carriers among lung cancer patients","volume":"8","author":"Yang","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"B80","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1470-2045(04)01414-7","article-title":"Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression","volume":"5","author":"Sun","year":"2004","journal-title":"Lancet Oncol"},{"issue":"4","key":"B81","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1006\/mgme.2000.3089","article-title":"Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers","volume":"71","author":"Yang","year":"2000","journal-title":"Mol Genet Metab"},{"issue":"12","key":"B82","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/NEJM198603203141202","article-title":"Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency","volume":"314","author":"Eriksson","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"B83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/hep.20815","article-title":"Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease","volume":"42","author":"Rudnick","year":"2005","journal-title":"Hepatology"},{"issue":"11","key":"B84","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3727\/096368912X657701","article-title":"Revascularization of pancreatic islet allografts is enhanced by alpha-1-antitrypsin under anti-inflammatory conditions","volume":"22","author":"Bellacen","year":"2013","journal-title":"Cell Transplant"},{"issue":"46","key":"B85","doi-asserted-by":"publisher","first-page":"27865","DOI":"10.1074\/jbc.270.46.27865","article-title":"Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line","volume":"270","author":"Wenger","year":"1995","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol Rev"},{"issue":"10","key":"B87","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"B88","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/carcin\/bgt034","article-title":"The yin and yang of nitric oxide in cancer progression","volume":"34","author":"Burke","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"B89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/156652412798376099","article-title":"Nitric oxide and cancer: the emerging role of S-nitrosylation","volume":"12","author":"Aranda","year":"2012","journal-title":"Curr Mol Med"},{"issue":"2","key":"B90","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2012.03.009","article-title":"Protein S-nitrosylation and cancer","volume":"320","author":"Wang","year":"2012","journal-title":"Cancer Lett"},{"issue":"7","key":"B91","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1074\/jbc.R111.285742","article-title":"Regulation by S-nitrosylation of protein post-translational modification","volume":"287","author":"Hess","year":"2012","journal-title":"J Biol Chem"},{"issue":"11","key":"B92","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1089\/ars.2012.5066","article-title":"Specificity in S-nitrosylation: a short-range mechanism for NO signaling?","volume":"19","author":"Mart\u00ednez-Ruiz","year":"2013","journal-title":"Antioxid Redox Signal"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T06:10:59Z","timestamp":1692598259000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,7]]},"references-count":92,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00559","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,7]]}}}